Trexquant Investment’s Astera Labs ALAB Stock Holding History

Trexquant Investment’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$869K	Buy	+1,800	New	+$478K	0.01%	1502

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trexquant Investment's ALAB Position: Q4 2025 in Review

Trexquant Investment sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 41,282 shares — an estimated $8.08M sold.

Trexquant Investment first reported a position in ALAB in Q4 2024 and held it in 2 quarters. The position peaked at $9.94M in Q4 2024. 701 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

Trexquant Investment reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
Trexquant Investment sold 41,282 Astera Labs shares in Q4 2025, an estimated $8.08M.
Trexquant Investment first reported a position in Astera Labs in Q4 2024 and held it in 2 quarters.
Trexquant Investment's Astera Labs position peaked at $9.94M in Q4 2024.
701 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.